Key Metrics
MARKET CAP
$20.01B
P/E RATIO
28.4
BETA
0.61
Less volatile
DIV YIELD
0.95%
52W HIGH
$114.44
52W LOW
$84.59
VOLATILITY
18.7%
30d annualized
Price Performance
30-DAY PRICE CHART
$85.99 → $100.99+17.44%
30 days agoToday
1-YEAR PERFORMANCE
$104.32 → $100.99-3.2%
ZBH | 52-week chartLast updated: 2/27/2026
Healthcare Sector Context
Competitors Analysis
Technical Analysis
Zimmer Biomet is currently trading at $100.99, which is 11.8% below its 52-week high. With a beta of 0.61, the stock shows lower sensitivity to market movements.
RSI (14)OVERBOUGHT
30-DAY TRENDBULLISH
VOLUME1.1M(Below avg)
Frequently Asked Questions
Is ZBH a good buy right now?
Zimmer Biomet trades at 28.4x earnings. This is near market average. Current risk level is Medium based on 18.7% volatility.
Does ZBH pay dividends?
Yes, Zimmer Biomet offers a dividend yield of 0.95%. This translates to approximately $0.96 per share annually.
How volatile is ZBH?
With 30-day annualized volatility of 18.7% and beta of 0.61,ZBH is classified as Medium risk. The stock tends to be more stable than the market average.
Related Assets
LLYANALYZE →
Eli Lilly and Company
NVOANALYZE →
Novo Nordisk A/S
UNHANALYZE →
UnitedHealth Group
JNJANALYZE →
Johnson & Johnson
ABBVANALYZE →
AbbVie Inc.
Track ZBH Live
Add Zimmer Biomet to your Portfolio Terminal for real-time alerts and risk updates.
OPEN TERMINALLast updated: 2/27/2026, 2:03:51 PM